We have collected information about Targeting Anticancer Drug Delivery To Pancreatic Cancer for you. Follow the links to find out details on Targeting Anticancer Drug Delivery To Pancreatic Cancer.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394772/
Jul 11, 2012 · The present report is the first to describe that targeted delivery of a cytotoxic drug as an L-fucose nanoconjugate can efficiently inhibit in vivo growth of pancreatic cancer cells. Furthermore, the L-fucose nanoparticles that we developed can be exploited as delivery vehicles for other anticancer drugs.Author: Makoto Yoshida, Rishu Takimoto, Kazuyuki Murase, Yasushi Sato, Masahiro Hirakawa, Fumito Tamura, Tsu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815202/
Urokinase plasminogen activator receptor (uPAR) is highly expressed on most of pancreatic cancer cells, and can be used as an optimal surface molecule for receptor-targeted therapy in pancreatic cancer. An uPAR-targeted drug or toxin delivery system could selectively kill the uPAR-expressing tumor cells [ …
https://www.ncbi.nlm.nih.gov/pubmed/22808043/
Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach. Yoshida M(1), Takimoto R, Murase K, Sato Y, Hirakawa M, Tamura F, Sato T, Iyama S, Osuga T, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.Author: Makoto Yoshida, Rishu Takimoto, Kazuyuki Murase, Yasushi Sato, Masahiro Hirakawa, Fumito Tamura, Tsu...
https://www.sciencedirect.com/science/article/pii/S0304419X09000729
Targeted drug delivery models in pancreatic cancer. Liposomes, nanoparticles, and carbon nanotubes are most commonly used vectors to deliver cancer chemotherapy drugs and other therapeutic agents such as shRNA, tumor suppressor gene, suicide gene, oncolytic virus, small molecule inhibitor, and antibody for pancreatic cancer treatment.Author: Xianjun Yu, Yuqing Zhang, Changyi Chen, Qizhi Yao, Min Li
https://www.researchgate.net/publication/229162089_Targeting_Anticancer_Drug_Delivery_to_Pancreatic_Cancer_Cells_Using_a_Fucose-Bound_Nanoparticle_Approach
Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach Article (PDF Available) in PLoS ONE 7(7):e39545 · July 2012 with 316 Reads
https://www.cancer.org/cancer/pancreatic-cancer/treating/targeted-therapy.html
Erlotinib (Tarceva) is a drug that targets a protein on cancer cells called EGFR, which normally helps the cells grow. In people with advanced pancreatic cancer, this drug can be given along with the chemo drug gemcitabine. Some people may benefit more from this combination than others.
https://www.nature.com/articles/s41392-017-0004-3
Mar 16, 2018 · Graphene-based polyurethane nanohybrids have been prepared by grafting long chain polyurethane onto the surface of functionalized graphene oxide for sustained drug delivery of an anticancer drug ...Author: Sudipta Senapati, Arun Kumar Mahanta, Sunil Kumar, Pralay Maiti
Searching for Targeting Anticancer Drug Delivery To Pancreatic Cancer?
You can just click the links above. The data is collected for you.
